Vicente Reynal
Analyst · Baird. Your line is open. Please go ahead
19:09 Thank you, Vik. And turning to Slide 13, in our Industrial Technologies and Service segment, organic revenue was up 11%. The team delivered strong adjusted EBITDA, which rose 10% year-over-year and an adjusted EBITDA margin of 25.7%, up 20 basis points sequentially with an incremental margin of 23%. As a reminder, we are overcoming a very strong comp from Q4 2020 of 400 basis point margin expansion. However, important to highlight as well that on a 2-year clip the team has delivered 360 basis point margin improvement. Organic orders were up 19%. 19:55 Starting with compressors, we saw orders up in the low 20% and a further breakdown shows orders for oil-free products growing at over 15% and oil lubricated products growing at over 25%. The Americas team delivered strong performance with orders in North America up mid-20s, while Latin America was up high '20s. In Mainland Europe, orders were up high teens, while India and the Middle East were down low-single digit. Asia Pacific continues to perform very well with orders of approximately 20% driven by low 20% growth in China and high-teens growth across the rest of Asia Pacific. 20:39 In the vacuum and blower product line, orders were up approximately 20% on a global basis. Moving next to the power tools and lifting, orders for the total business were up approximately 20% and saw continued positive momentum, driven mainly by our enhanced e-commerce capabilities and improved execution on new product launches. On our sustainable innovation in action, today we want to highlight our recently acquired company. Jorc is a manufacturer of condensate drains, oil and water separators and air saving products, which are part of the compressor ecosystem. These products focus on improving overall system performance and creating energy efficiency through efficient use and recycling of fluids and air, which helps our customers achieve their environmental goals. We're very excited about these complementary acquisition as we continue to expand our offerings with the compressor ecosystem, as well as the impact that Jorc will have as we scale up and expand geographically. 21:47 Moving to Slide 14. Revenue in the Precision and Science Technologies segment grew 15% organically, which remains encouraging given the tough comps due to COVID related orders and revenue in Q4 of 2020 for the medical business. Additionally, the PS team delivered well adjusted EBITDA of $78 million, which was up 22% year-over-year. Adjusted EBITDA margin was 26.8%, down 400 basis points year-over-year, primarily driven by the impact of M&A. Again, the segment was down 120 basis points, excluding the impact of acquisitions in Q4 2021 with an adjusted EBITDA margin of 29.6% ex-M&A. Overall, organic orders were up 14%, driven by the Medical and Dosatron businesses, which were up strong double digits in the quarter and as they serve lab, life sciences, water and animal health end markets. Incremental margins were 17% as reported and 21% when excluding the impact of M&A. 22:55 Looking at the sustainable innovation in action portion of the slide, we're highlighting our recent Tuthill Pumps acquisition. Tuthill Pumps manufacturers gear and piston pumps for sustainable end markets, such as medical and lab, food and beverage, water and wastewater. Tuthill’s D series magnetically coupled pumps are used in lab applications such as hematology analysis, as well as other chemistry analyzers. The business is complementary to our existing portfolio, and we are well underway with integration of this business. 23:29 Moving to Slide 15. We're pleased to introduce our 2022 guidance. In aggregate, we expect total company revenue to be up 11% to 13% with the first half up 12% to 14% and the second half up 9% to 11%. We expect organic revenue growth of 7% to 9% for the total company with 7% to 9% growth expected in ITS and 8% to 10% growth in PST. FX is expected to contribute a headwind of approximately 1% with 1% to 2% coming in the first half of 2022 and 0% to 1% in the second half. M&A announced and closed to date is expected to contribute an incremental $225 million in revenue. This outlook reflects normal seasonality in the business, which is typically lightest in Q1, similarly stronger in both Q2 and Q3 on an absolute basis and strongest in the fourth quarter. We do not see quarterly phasing to be materially different from 2021. We expect total adjusted EBITDA for the company to be $1.375 billion to $1.415 billion, including corporate cost of approximately $135 million spread evenly over each quarter. 24:51 This yields an incremental margin of approximately 35% for the total company with positive margin expansion expected to sequentially from Q1 through Q4 of 2022. Free cash flow conversion to adjusted net income is expected to be greater than 100%. We anticipate our adjusted tax rate to normalize in the low '20s for the reasons Vik mentioned earlier with CapEx representing approximately 2% of revenue. 25:18 Looking at Q1 specifically, we expect double-digit revenue growth year-over-year with ITS growing high single-digits organically and PST growing low double digits. We also expect flat to slightly positive margin expansion due to the tough year-over-year comparison, ongoing supply chain constraints and inflationary pressures. 25:41 Turning to Slide 16. As we wrap up today's call, I want to reiterate that Ingersoll Rand is in an outstanding position. 2022 is poised to be a strong year despite the challenging environment. To our employees, I want to again thank you for your relentless efforts to execute and solve tough problems in 2021. We accomplished an incredible amount together and we move into 2022 as an even stronger action oriented team. We continue to invest for growth, both organically and inorganically with a focus on increase in the quality of our total portfolio, while serving as an industry-leading sustainable company. IRX is truly our backbone and drives every process in our company, enabling outperformance and ensuring our global team is speaking one language, focused on capturing growth opportunities driving innovation and efficiencies and acting boldly to win in the marketplace. 26:42 Our balance sheet is very strong and with our discipline and comprehensive capital allocation strategy, we have significant ability to redeploy capital to compound earnings and continue our track record of market outperformance. 26:55 With that, I'll turn the call back to the operator and open for Q&A.